Cover Image

Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Jingya Gao, Feifang Hu, Wei Ma
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Statistics in Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Group Response‐Adaptive Randomization With Delayed and Missing Responses
by: Guannan Zhai, et al.
Published: (2024)

Exact Randomized Two‐Stage Phase 2 Clinical Trial Designs for Two Binary Co‐Primary Endpoints
by: Hyejung Jung, et al.
Published: (2026)

Adaptive Designs in Trials With Time‐to‐Event Endpoints and Covariate Adjustment
by: Daniel Backenroth, et al.
Published: (2026)

Bayesian Response‐Adaptive Randomization for Cluster Randomized Controlled Trials
by: Yunyi Liu, et al.
Published: (2026)

Safety‐Driven Response Adaptive Randomization: An Application in Noninferiority Oncology Trials
by: Maria Vittoria Chiaruttini, et al.
Published: (2026)

Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
by: Xiaotian Chen, et al.
Published: (2025)

The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints
by: Xinran Huang, et al.
Published: (2024)

Testing for Similarity of Dose Response in Multiregional Clinical Trials
by: Holger Dette, et al.
Published: (2025)

Preference‐Informed Cluster Randomized Design for Pragmatic Clinical Trials
by: Yuwei Cheng, et al.
Published: (2026)

Adaptive Biomarker‐Based Design for Early Phase Clinical Trials
by: Alessandra Serra, et al.
Published: (2025)

A Nonparametric Global Win Probability Approach to the Analysis and Sizing of Randomized Controlled Trials With Multiple Endpoints of Different Scales and Missing Data: Beyond O'Brien–Wei–Lachin
by: Guangyong Zou, et al.
Published: (2024)

Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints
by: Ryota Ishii, et al.
Published: (2025)

Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials
by: Xi Fang, et al.
Published: (2026)

Dynamic Borrowing From Historical Controls via the Synthetic Prior With Covariates in Randomized Clinical Trials
by: Daniel E. Schwartz, et al.
Published: (2026)

Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis
by: Ruoyuan Qian, et al.
Published: (2025)

MARGO: Machine Learning‐Assisted Adaptive Randomization for Group Sequential Trials Based on Overlap Weights
by: Yeonhee Park, et al.
Published: (2025)

RMST for Interval‐Censored Data in Oncology Clinical Trials
by: Xiyuan Gao, et al.
Published: (2025)

Futility Monitoring in Clinical Trials
by: Ana M. Ortega‐Villa, et al.
Published: (2025)

Regression Adjustment in Covariate‐Adaptive Randomized Experiments With Missing Covariates
by: Wanjia Fu, et al.
Published: (2025)

Model‐Robust Standardization in Cluster‐Randomized Trials
by: Fan Li, et al.
Published: (2025)

Correction to “Model‐Robust Standardization in Cluster‐Randomized Trials”
Published: (2026)

On Anticipation Effect in Stepped Wedge Cluster Randomized Trials
by: Hao Wang, et al.
Published: (2026)

Sample Size and Power Calculations With Win Measures Based on Hierarchical Endpoints
by: Huiman Barnhart, et al.
Published: (2025)

A Note on the Sample Size Formula for a Win Ratio Endpoint
by: Se Yoon Lee
Published: (2025)

Negative Control Outcome Adjustment in Early‐Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants
by: Ethan Ashby, et al.
Published: (2025)

Sample Size Adjustment in Sequential Multiple Assignment Randomized Trials
by: Liwen Wu, et al.
Published: (2025)

An Empirical Assessment of the Cost of Dichotomization of the Outcome of Clinical Trials
by: Erik W. van Zwet, et al.
Published: (2026)

Patient‐Centric Pragmatic Clinical Trials: Opening the DOOR
by: Scott R. Evans, et al.
Published: (2026)

Time‐Varying Treatment Effect Models in Stepped‐Wedge Cluster‐Randomized Trials With Multiple Interventions
by: Zhe Chen, et al.
Published: (2026)

The Cox Model With Adaptive Fused Group Bridge Penalty to Incorporate Historical Data Into the Analysis of Clinical Trials With an Application to BMT CTN 1101
by: Xi Fang, et al.
Published: (2025)

Semiparametric Estimation of Relative Causal Effects in Randomized Controlled Trials With Noncompliance
by: Wenli Liu, et al.
Published: (2025)

Bayesian Ordered Lattice Design for Phase I Clinical Trials
by: Gi‐Ming Wang, et al.
Published: (2026)

Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo
by: Fei Gao, et al.
Published: (2025)

Dynamic Borrowing With a Bias‐Tolerance Cap in Augmented Randomized Controlled Trials
by: Kota Sawada, et al.
Published: (2026)

Designing Stepped Wedge Cluster Randomized Trials With a Baseline Measurement of the Outcome
by: Kendra Davis‐Plourde, et al.
Published: (2025)

A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine
by: Yuan Li, et al.
Published: (2025)

On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
by: Adrien Ollier, et al.
Published: (2025)

Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation Principles
by: Kim May Lee, et al.
Published: (2026)

Bayesian Prediction of Event Times Using Mixture Model for Blinded Randomized Controlled Trials
by: Jingyan Fu, et al.
Published: (2025)

Modern Causal Inference Approaches to Improve Power for Subgroup Analysis in Randomized Controlled Trials
by: Antonio D'Alessandro, et al.
Published: (2026)